Back

Cancer therapies and vascular toxicities

13 April 2024 (16:55 - 17:10)
Organised by: Logo
Congress Presentation Part of: The immune system in the pathogenesis and treatment of cancer therapy-induced cardiovascular toxicity Leukocytes, Inflammation, Immunity CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science

About the speaker

Photo
Professor Ioanna Andreadou

National & Kapodistrian University of Athens, Athens (Greece)

3 More presentations in this session

Presentation thumbnail
Cardioprotection via modulation of the immune response
Doctor Z. Varga (Budapest, HU)
Slides
Presentation thumbnail
Accelerated atherosclerosis by immune checkpoint inhibitors
Doctor N. Van Es (Amsterdam, NL)
Slides
Presentation thumbnail
CDK4/6 inhibitor ribociclib induces cardiotoxicity in dynamic engineered heart tissues, mitigated by E2F1 overexpression
Mr I. Dias (Groningen, NL)
Abstract Slides

Access the full session

Session thumbnail
The immune system in the pathogenesis and treatment of cancer therapy-induced cardiovascular toxicity

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

13 April 2024 16:55 CET
You may be interested in
thumbnail
Webinar
Multidisciplinary strategies for monitoring and managing cardiovascular toxicity in patients with cancer
18 February 2025
thumbnail
Congress Presentation
The effect of anthracycline-based chemotherapy on endothelial function and arterial stiffness in breast cancer patients
28 August 2023
thumbnail
Congress Session
New insights into cancer therapy-related cardiac dysfunction
18 May 2025
thumbnail
ESC Journals
Breast cancer and cardiovascular health
25 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources